In 155 patients followed for an average of 14 months, cloth-covered Starr-Edwards prostheses had a high incidence of early fatal thrombo-embolus after mitral valve replacement.
Cohort (n=155)
What are the thrombo-embolic complications associated with cloth-covered Starr-Edwards prostheses No. 2300 aortic and No. 6300 mitral?
Cloth-covered Starr-Edwards prostheses are associated with significant thrombo-embolic risks that vary by valve position, complicated by hazardous anticoagulant control.
The thrombo-embolic complications of the cloth-covered Starr-Edwards prostheses No. 2300 aortic and No. 6300 mitral followed for an average of 14 months in 155 patients are reviewed. There was a high incidence of early fatal and disabling thrombo-embolus in patients having mitral valve replacement. Late emboli were more common after aortic valve replacement. Anticoagulant control was unsatisfactory and not without hazards.
Cleland et al. (Mon,) conducted a cohort in Aortic or mitral valve replacement (n=155). Cloth-covered Starr-Edwards prostheses No. 2300 aortic and No. 6300 mitral was evaluated on Thrombo-embolic complications. In 155 patients followed for an average of 14 months, cloth-covered Starr-Edwards prostheses had a high incidence of early fatal thrombo-embolus after mitral valve replacement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: